$37M sweet spot round size
Most of their 10 investments are in rounds between $15M and $60M
1999
KAHR-medical Ltd. raised $47M on June 16, 2021
Investors: Cancer Focus Fund, Hadasit Bio-Holdings Ltd., Flerie Invest, Peregrine Ventures and DAFNA Capital Management, LLC
Gemini Therapeutics raised $95M on February 8, 2021
Investors: Suvretta Capital Management LLC, OrbiMed Advisors, Foresite Capital, Lightstone Ventures, Atlas Venture, Wellington Management, Wu Capital (双湖资本) and DAFNA Capital Management, LLC
ObsEva SA raised $60M on October 10, 2017
Investors: Omega Funds, Aisling Capital, New Leaf Venture Partners, Venrock, Sofinnova Ventures, Russia technology fund and DAFNA Capital Management, LLC
Ardelyx, Inc. raised $110M on July 18, 2016
Investors: 上海市东方世纪消费品发展促进中心, Perceptive Advisors, Quadrille Capital, RA Capital Management, L.P. and DAFNA Capital Management, LLC
Corbus Pharmaceuticals raised $15M on June 10, 2016
Investors: Perceptive Advisors and DAFNA Capital Management, LLC
argenx raised $33M on June 3, 2016
Investors: Burrage Capital Management, Aquila Capital, MPM Capital and DAFNA Capital Management, LLC
Minerva Neurosciences raised $31M on March 24, 2015
Investors: HCP Ltd, Index Ventures, Perceptive Advisors and DAFNA Capital Management, LLC
Cascadian Therapeutics, Inc. raised $15M on September 24, 2010
Investors: Strauss & Partnere, Hartz Real Estate, Cowen Inc. and DAFNA Capital Management, LLC
Raptor Pharmaceuticals (Horizon Pharma PLC) raised $15M on August 9, 2010
Investors: Lincoln Park Capital, LLC and DAFNA Capital Management, LLC
Cancervax (merged to Micromet) raised $40M on October 3, 2008
Investors: Merlin Nexus, Index Ventures, Abingworth and DAFNA Capital Management, LLC